NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

This is false.

Shares fell from $2,51 to ~$0,70 the day the TLD data was released. And it has not materially shown ANY higher price for over six months.

Moreover it stayed flat YTD after, generally, with some fluctuation below and above, but generally flat. And before 5/10 it was run up by false hopes loudly proclaimed by many shareholders. I understand the sentiment, but that is the reality. It did not get anywhere near $2.51 however and it went back to where it was before it was pumped.

Optune is an external device. It does not have the same level of complexity for its trials and could statistically and hypothetically predict it’s survival stats and get approved based on PFS, which is often flawed.

NWBO went with Survival, and yes that takes a long time and there were financial challenges during the financial crisis and complexities discovered with immunotherapies during the time of the trial including in other, similar trials. However NWBO has followed the rules and is in the process of applying and has not been rejected. Nor did they violate any FDA rules and they made changes to OS while still blinded, again, consistent with FDA guidelines.